Physician profile
Jonathan B Hancock
NPI 1497048011
$7,205.00
in general payments reported to CMS, 2019-2025
18 companies · $1,634 in 2025
The $1,634 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,158 · 2020: $130 · 2021: $3,145 · 2022: $295 · 2023: $677 · 2024: $167 · 2025: $1,634.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,859 · Food and Beverage: $619.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,858.61 |
| Food and Beverage | $618.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $5,116.80 | 2021-2025 | Oxford, Arcos |
| Gemini Mountain Medical, LLC | $990.00 | 2019 | |
| Heron Therapeutics, INC. | $222.59 | 2022-2025 | Zynrelef |
| Stryker Corporation | $210.72 | 2019-2025 | Triathlon |
| Sanara Medtech INC. | $143.00 | 2022 | |
| Amgen INC. | $80.47 | 2019-2021 | |
| Pacira Therapeutics, INC. | $73.01 | 2019-2020 | |
| Orthalign INC | $65.75 | 2022 | |
| Organogenesis INC. | $63.55 | 2021-2023 | Puraply |
| Smith+Nephew, INC. | $50.63 | 2021-2024 | Trigen Intertan |
| Medtronic, INC. | $41.91 | 2023-2025 | Aquamantys(Tm), V-Loc 180 |
| Abbott Laboratories | $30.48 | 2024 | Proclaim |
| Active Medical, LLC | $25.30 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $23.20 | 2020 | |
| Avanos Medical | $21.42 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hikma Pharmaceuticals USA | $21.00 | 2022 | |
| Kci USA, INC. | $17.11 | 2021 | |
| Fidia Pharma USA INC. | $8.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Hancock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.